Transition of pemphigus vulgaris into pemphigus foliaceus confirmed by antidesmoglein ELISA profile

International Journal of Dermatology

Volumn 41, Issue 8, 2002, Pages 525-527

  Tóth, Gábor G ^a   Pas, Hendri H ^a   Jonkman, Marcel F ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIDESMOGLEIN 1; ANTIDESMOGLEIN 3; AZATHIOPRINE; CLOBETASOL DIPROPIONATE; DEXAMETHASONE; GLUCOCORTICOID; IMMUNOGLOBULIN G; PREDNISOLONE; UNCLASSIFIED DRUG;

ACANTHOLYSIS; ADULT; ANAMNESIS; ANTIBODY PRODUCTION; ANTIBODY TITER; CASE REPORT; CLINICAL FEATURE; DISEASE ACTIVITY; DISEASE COURSE; DISEASE EXACERBATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE; LETTER; MALE; PEMPHIGUS FOLIACEUS; PEMPHIGUS VULGARIS; REMISSION; SCALP;

EID: 0036671524     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.2002.15452.x     Document Type: Letter

References (8)

1. Transition from pemphigus vulgaris to pemphigus foliaceus
2. Immunoblot assay as an aid to the diagnoses of unclassified cases of pemphigus
3. Pemphigus vulgaris transforming into pemphigus foliaceus and their coexistence
4. The clinical transition between pemphigus foliaceus and pemphigus vulgaris correlates well with the changes in autoantibody profile assessed by an enzyme-linked immunosorbent assay
5. Development of pemphigus vulgaris in a patient with pemphigus foliaceus: Antidesmoglein antibody profile shift confirmed by enzyme-linked immunosorbent assay
6. Therapy of pemphigus vulgaris
7. Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins
8. Late development of antidesmoglein 1 antibodies in pemphigus vulgaris: Correlation with disease progression